| Previous close | 4,752.00 |
| Open | 4,732.00 |
| Bid | 4,695.00 x 54200 |
| Ask | 4,800.00 x 67200 |
| Day's range | 4,718.50 - 4,784.00 |
| 52-week range | 2,879.89 - 5,643.60 |
| Volume | 1,904,613 |
| Avg. volume | 4,733,931 |
| Market cap | 109.26B |
| Beta | 0.96 |
| PE ratio (TTM) | 19.17 |
| EPS (TTM) | 249.2 |
| Earnings date | N/A |
| Dividend & yield | 2.16 (3.59%) |
| Ex-dividend date | 2017-08-17 |
| 1y target est | 5,734.71 |
- Fool.co.uk•3 days ago
Is Neil Woodford wrong about British American Tobacco plc and GlaxoSmithKline plc?
Should you follow Neil Woodford and sell GlaxoSmithKline plc (LON: GSK) and British American Tobacco plc (LON: BATS)?
- Fool.co.uk•3 days ago
British American Tobacco plc isn’t the only bargain stock I’m avoiding right now
Royston Wild explains looks at another London-quoted stock standing on shaky ground like British American Tobacco plc (LON: BATS).
- Reuters - UK Focus•3 days ago
Philip Morris bond tries to find the right snuff
Tobacco company Philip Morris International amassed an order book of US$2.4bn for its US$1.25bn investment-grade bond deal on Monday, leaving the trade slightly less than twice covered. The sector's second deal in as many weeks - after the recent US$17.25bn offering from rival British American Tobacco (Kuala Lumpur: 4162.KL - news) - left some feeling oversupplied, one bond buyer said. "We just had a big tobacco deal," he told IFR.
